文献速递免疫规划慢病防控与筛查

疫苗安全数据链网络中儿童炎症性肠病发病率及与轮状病毒疫苗关联评估

Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
PubMed 文献 · Vaccine · 2021-05-26

嵌套病例对照研究显示,调整后轮状病毒疫苗接种与IBD的比值比为0.72(95%CI 0.19-2.65),提示轮状病毒疫苗与IBD发生无关。

要点

  • 10岁以下儿童IBD粗发病率十年间略有上升,趋势检验P=0.046。
  • 轮状病毒疫苗接种与IBD关联的调整OR为0.72(95%CI 0.19-2.65)。
  • 数据不支持轮状病毒疫苗增加儿童IBD风险。

核心结论

  • 大型儿科队列显示十年间幼儿IBD发病率总体小幅上升。
  • 数据提示轮状病毒疫苗接种与IBD发生无关。

研究设计与样本

  • 嵌套病例对照研究,病例经病历复核确认,按出生日期、性别和研究站点匹配非IBD对照。
  • 采用条件logistic回归评估轮状病毒疫苗接种与IBD的关联。

主要发现

  • IBD粗发病率在研究期间略有上升,趋势P=0.046。
  • 333例中227例(68%)出生于2007年之前。
  • 任何轮状病毒疫苗接种与IBD的调整OR为0.72(95%CI 0.19-2.65)。

临床怎么用

  • 可为家长和临床医生提供轮状病毒疫苗不增加儿童IBD风险的证据支持。
  • 对幼儿IBD发病率小幅上升需持续监测,但不应归因于轮状病毒疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have reported an increase in Inflammatory bowel disease (IBD) incidence in young children, highlighting the need to better understand risk factors for the development of IBD. Licensed for use in infants in 2006, the oral, live-attenuated rotavirus vaccine has biologic plausibility for instigating inflammation of the gut mucosa as a pathway to immune dysregulation. METHODS: Over a ten-year period, we evaluated incidence of IBD within a cohort of children under the age of ten, enrolled in seven integrated healthcare delivery systems. We conducted a nested case-control study to evaluate the association between rotavirus vaccination and IBD using conditional logistic regression. Cases were confirmed via medical record review and matched to non-IBD controls on date of birth, sex, and study site. RESULTS: Among 2.4 million children under the age of 10 years, 333 cases of IBD were identified with onset between 2007 and 2016. The crude incidence of IBD increased slightly over the study period (p-value for trend = 0.046). Of the 333 cases, 227 (68%) were born prior to 2007. Forty-two cases born in 2007 or later, with continuous enrollment since birth were included in the case-control study and matched to 210 controls. The adjusted odds ratio for any rotavirus vaccination in IBD cases, compared to matched controls, was 0.72 (95% confidence interval 0.19-2.65). CONCLUSIONS: Data from this large pediatric cohort demonstrate a small overall increase in IBD incidence in young children over a ten-year period. The data suggest that rotavirus vaccination is not associated with development of IBD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liles E, Irving SA, Dandamudi P, et al. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine. 2021. PMID: 34052066. doi:10.1016/j.vaccine.2021.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。